BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230718
DTEND;VALUE=DATE:20230721
DTSTAMP:20260516T065011
CREATED:20230414T110135Z
LAST-MODIFIED:20230414T110135Z
UID:37065-1689638400-1689897599@www.pharmajournalist.com
SUMMARY:3rd Tumor Myeloid-Directed Therapies Summit
DESCRIPTION:The 3rd Annual Tumor Myeloid-Directed Therapies Summit returns with over 75% new speakers to share insights across a range of myeloid targets\, including CD40\, CD39\, LILRB2\, CLEC-1 as well as CAR-M therapies. The one-stop shop continues to be your go-to forum to accelerate myeloid therapy progression by determining optimal combination strategy\, optimize translational studies\, discover novel targets\, and guarantee patient safety. Connect with this up-and-coming community to reinvent targeting and harness the untapped potential of the myeloid. \nCollaborate and learn from myeloid experts across industry and academia over 3 in-depth days of content\, as they address the key bottlenecks limiting the efficacy and safety of these exciting treatments\, including in vivo models\, biomarkers of response\, combination rationale\, and myeloid biology to accelerate myeloid directed therapies. \nTo know more visit: https://ter.li/tm1bzy
URL:https://www.pharmajournalist.com/event/3rd-tumor-myeloid-directed-therapies-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR